Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy

Parkinsonism and Related Disorders

Volumn 15, Issue 3, 2009, Pages 242-244

  De Rosa, Anna ^a   Criscuolo, Chiara ^a   Mancini, Pietro ^a   De Martino, Marina ^a   Giordano, Ilaria Anna ^a   Pappatà, Sabina ^b   Filla, Alessandro ^a   De Michele, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

18F deoxy glucose PET; G2019S mutation; LRRK2; Parkinson's disease

Indexed keywords

AMANTADINE; BENSERAZIDE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; GLUCOSE METABOLISM; HALLUCINATION; HETEROZYGOTE; HUMAN; ITALY; JEALOUS DELUSION; MAJOR CLINICAL STUDY; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; FLUORODEOXYGLUCOSE F18; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; GLYCINE; HUMANS; ITALY; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN-SERINE-THREONINE KINASES; SERINE; YOUNG ADULT;

EID: 60549089055     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.05.011     Document Type: Article

References (15)

1. Gasser T. Update on the genetics of Parkinson's disease. Mov Disord 22 Suppl. 17 (2007) S343-S350
2. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
3. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
4. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 (2005) 672-680
5. Goldwurm S., Zini M., Mariani L., Tesei S., Miceli R., Sironi F., et al. Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology 68 (2007) 1141-1143
6. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., et al. The G2019 S mutation is uncommon in Asian cohort of Parkinson's disease patients. Neurosci Lett 384 (2005) 327-329
7. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
8. Marongiu R., Ghezzi D., Ialongo T., Soleti F., Elia A., Cavone S., et al. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. Mov Disord 21 (2006) 1232-1235
9. Cossu G., van Doeselaar M., Deriu M., Melis M., Molari A., Di Fonzo A., et al. LRRK2 mutations and Parkinson's disease in Sardinia - a Mediterranean genetic isolate. Parkinsonism Relat Disord 13 (2007) 17-21
10. Xiromerisiou G., Hadjigeorgiou G.M., Gourbali V., Johnson J., Papakonstantinou I., Papadimitriou A., et al. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants. Eur J Neurol 14 (2007) 7-11
11. De Michele G., Filla A., Volpe G., De Marco V., Gogliettino A., Ambrosio G., et al. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord 11 (1996) 17-23
12. Goldwurm S., Zini M., Di Fonzo A., De Gaspari D., Siri C., Simons E.J., et al. LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat Disord 12 (2006) 410-419
13. Khan N.L., Jain S., Lynch J.M., Pavese N., Abou-Sleiman P., Holton J.L., et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 128 (2005) 2786-2796
14. Gotham A.M., Brown R.G., and Marsden C.D. Frontal cognitive function in patients with Parkinson disease on and off levodopa. Brain 111 (1998) 299-321
15. Berding G., Odin P., Brooks D.J., Nikkhah G., Matthies C., Peschel T., et al. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 16 (2001) 1014-1022